Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, U.S.A.
Division of Pediatric Otolaryngology, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, U.S.A.
Laryngoscope. 2021 Feb;131(2):E642-E648. doi: 10.1002/lary.28752. Epub 2020 May 22.
OBJECTIVES/HYPOTHESIS: Pediatric chronic rhinosinusitis (CRS) is a prevalent disease with few objective measurements available to predict which patients will require surgical intervention. The Lund-Mackay (LM) score for computed tomography (CT) scans is one objective data point available for the adult population; however, a dedicated scoring system in the pediatric population has not been popularized. We present a Pediatric Sinus Staging System (PSSS) that considers both opacification and the varying developmental stages of each sinus.
Retrospective chart review.
We analyzed CT scans of pediatric patients with a diagnosis of CRS. Both LM and PSSS scores were calculated for each scan. Groups were formed based on treatment outcomes and included patients who were treated successfully with medical therapy and/or adenoidectomy (med/adenoid), patients who required functional endoscopic sinus surgery (FESS), and patients who required revision FESS.
Overall, 76 patient scans were reviewed. PSSS values were significantly less than LM for the control group (P = .001) and significantly higher for patients with cystic fibrosis (P = .027) and with CRS with polyps (P = .001). The ideal cutoff for PSSS to distinguish between med/adenoid and single FESS treatment with a sensitivity 90.6% and specificity of 50.0% was ≥2.
The PSSS gives a more descriptive score by accounting for the opacification and pneumatization of each sinus. Our current results show similar values between PSSS and LM scores, which suggests internal validity. In addition, a PSSS score of ≥2 may help physicians better counsel families on the likelihood of requiring FESS. Further investigation is needed to fully validate the PSSS.
3b Laryngoscope, 131:E642-E648, 2021.
目的/假设:小儿慢性鼻-鼻窦炎(CRS)是一种常见疾病,目前可用于预测哪些患者需要手术干预的客观测量方法较少。计算机断层扫描(CT)的 Lund-Mackay(LM)评分是成人人群中可用的一个客观数据点;然而,小儿人群中尚未普及专门的评分系统。我们提出了一种小儿鼻窦分期系统(PSSS),该系统同时考虑了鼻窦的混浊程度和各个鼻窦的不同发育阶段。
回顾性图表审查。
我们分析了诊断为 CRS 的小儿患者的 CT 扫描。为每个扫描计算了 LM 和 PSSS 评分。根据治疗结果形成了组,包括经药物治疗和/或腺样体切除术(药物/腺样体)成功治疗的患者、需要功能性内镜鼻窦手术(FESS)的患者以及需要修正 FESS 的患者。
总体而言,共回顾了 76 例患者的扫描。对照组的 PSSS 值明显低于 LM(P = .001),囊性纤维化(P = .027)和伴有息肉的 CRS 患者的 PSSS 值明显更高(P = .001)。PSSS 区分药物/腺样体和单一 FESS 治疗的最佳截断值为≥2,此时具有 90.6%的敏感性和 50.0%的特异性。
PSSS 通过考虑每个鼻窦的混浊和充气程度给出了更具描述性的评分。我们目前的结果表明 PSSS 与 LM 评分之间存在相似的值,这表明其具有内部有效性。此外,PSSS 评分≥2 可能有助于医生更好地告知家属需要 FESS 的可能性。需要进一步研究以充分验证 PSSS。
3b 喉镜,131:E642-E648,2021 年。